The symptoms of Classic Galactosemia typically appear shortly after birth, once the infant begins consuming milk. Common signs include poor feeding, vomiting, diarrhea, jaundice (yellowing of the skin and eyes), lethargy, and failure to thrive. If left untreated, the condition can lead to more severe complications such as liver damage, cataracts, intellectual disability, and increased risk of infections.

Diagnosing Classic Galactosemia involves a combination of clinical evaluation and laboratory tests. Newborn screening programs often include tests for galactosemia, which measure the levels of galactose or GALT enzyme activity in the blood. If the screening suggests galactosemia, further confirmatory tests, such as genetic testing to identify mutations in the GALT gene, are conducted to establish the diagnosis.

The primary treatment for Classic Galactosemia is a strict lifelong dietary restriction of galactose. This involves eliminating all sources of galactose, including milk and dairy products, from the diet. Infants are typically fed soy-based or elemental formulas. Regular monitoring by a healthcare team, including a dietitian, is essential to ensure nutritional needs are met while avoiding galactose.

With early diagnosis and strict dietary management, many individuals with Classic Galactosemia can lead relatively normal lives. However, some may still experience long-term complications, such as speech and learning difficulties, motor skill delays, and reproductive issues in females. Regular follow-up and supportive therapies can help manage these challenges.

Classic Galactosemia is an autosomal recessive genetic disorder, meaning that an individual must inherit two copies of the mutated GALT gene, one from each parent, to develop the condition. Carriers, who have only one copy of the mutated gene, typically do not show symptoms but can pass the gene to their offspring.

Classic Galactosemia is a rare condition, with an estimated incidence of 1 in 30,000 to 60,000 live births worldwide. The prevalence can vary among different populations and ethnic groups. Due to newborn screening programs, the condition is often detected early, allowing for prompt intervention.

In Classic Galactosemia, the deficiency of the GALT enzyme disrupts the normal metabolic pathway of galactose, leading to the accumulation of toxic substances such as galactose-1-phosphate and galactitol. These substances can cause damage to various organs and tissues, particularly the liver, eyes, and brain, resulting in the symptoms and complications associated with the disorder.

Currently, there is no way to prevent Classic Galactosemia, as it is a genetic condition. However, genetic counseling can be beneficial for families with a history of the disorder. Prospective parents can undergo carrier testing to assess their risk of having a child with galactosemia.

Classic Galactosemia is a genetic disorder that impairs the body's ability to process galactose, leading to a range of health issues if untreated. Early diagnosis through newborn screening and strict dietary management are crucial for preventing severe complications. While individuals with the condition may face long-term challenges, appropriate care and support can help them lead fulfilling lives.

If you or your child has been diagnosed with Classic Galactosemia, it's important to follow a galactose-free diet to prevent complications. Work closely with your healthcare team to monitor health and development. Regular check-ups and supportive therapies can help manage any long-term effects. Genetic counseling may be helpful for family planning and understanding the condition's inheritance pattern.